Filana Therapeutics, Inc. (FLNA): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2013-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$41.12M
Year ended 2013-12-31
+34.7%
3-year compound annual growth
2009-12-31: $20.56M2010-12-31: $16.81M2011-12-31: $11.48M2012-12-31: $10.89M2013-12-31: $41.12M$41.12M
2009-12-31 Revenue (USD) 2013-12-31
Period endedRevenueChange YoYSource filing
2013-12-31$41.12M+277.6%2016-03-03, From 2013-01-01
2012-12-31$10.89M-5.2%2015-02-18, From 2012-01-01
2011-12-31$11.48M-31.7%2014-02-05, From 2011-01-01
2010-12-31$16.81M-18.3%2013-02-08, From 2010-01-01
2009-12-31$20.56Mn/a2012-02-09, From 2009-01-01